Eduardo Setti

This inventor holds 19 USPTO granted patents and 4 published patent applications and 7 EPO patents, primarily in Kinase Modulation. Top assignees: Ambit Biosciences Corporation, Axys Pharmaceuticals, Inc., Merck + Co., Inc.. Active years: 2002-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eduardo Setti. Retrieved from https://idiyas.com/inventor/eduardo-setti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 4)

% Patents Active = 15.8

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 94(Granted Patents)

Location History:

San Diego, CA (US) (2015 - 2016)
San Mateo, CA (US) (2002 - 2018)

Company Filing History:

12 out of 39

Ambit Biosciences Corporation

patents

3 out of 40

Axys Pharmaceuticals, Inc.

Merck Frosst Canada & Co.

where one patent can have more than one assignee

Years Active: 2002-2018

Loading Chart...

Areas of Expertise:

RAF Kinase Modulators

JAK Kinase Modulators

Protease Inhibitors

Pyrazolylaminoquinazoline

Cysteine Protease Inhibitors

Therapeutic Agents

Pharmaceutical Compositions

Optically Active Compounds

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10053430 - RAF kinase modulator compounds and methods of use thereof (2018-08-21),

2. 9730937 - RAF kinase modulator compounds and methods of use thereof (2017-08-15),

3. 9320739 - RAF kinase modulator compounds and methods of use thereof (2016-04-26),

4. 9308207 - JAK kinase modulating compounds and methods of use thereof (2016-04-12),

5. 9295672 - Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof (2016-03-29),

6. 8969587 - RAF kinase modulator compounds and methods of use thereof (2015-03-03),

7. 8952020 - Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof (2015-02-10),

8. 8927711 - JAK kinase modulating compounds and methods of use thereof (2015-01-06),

9. 8912324 - Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof (2014-12-16),

10. 8703943 - Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof (2014-04-22),

11. 8618289 - RAF kinase modulator compounds and methods of use thereof (2013-12-31),

12. 8349851 - JAK kinase modulating compounds and methods of use thereof (2013-01-08),

13. 8013186 - Haloalkyl containing compounds as cysteine protease inhibitors (2011-09-06),

14. 7371747 - Cyanoalkylamino derivatives as protease inhibitors (2008-05-13),

15. 7368476 - Hydroxamates as therapeutic agents (2008-05-06),

Title: Eduardo Setti - Innovative Inventor from San Mateo

Introduction: Eduardo Setti is a renowned inventor based in San Mateo, California, known for his groundbreaking contributions to various fields of technology.

Latest Patents: Eduardo Setti holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With over two decades of experience in the industry, Eduardo Setti has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Eduardo Setti has collaborated with top engineers, scientists, and designers to bring his ideas to life, fostering a culture of innovation and creativity in every project he undertakes.

Conclusion: Eduardo Setti's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, making him a true pioneer in the world of technology.

Profile summary based on public USPTO records.